ArticleCureus2026
Fosfomycin Susceptibility Patterns Among Uropathogens and Clinical Predictors of Resistance: A Cross-Sectional Study at a Tertiary Care Centre in Northern India.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionUrinary tract infections (UTIs) represent a significant global health concern, with
methodThis cross-sectional study was conducted at All India Institute of Medical Sciences (AIIMS), Rishikesh, from January to May 2025. Antimicrobial susceptibility testing (AST) of 407 culture-positive UTI isolates was performed using the VITEK-2 compact system (GN-235 cards) (bioMérieux SA, Marcy-l'Étoile, France), with results interpreted as per Clinical and Laboratory Standards Institute (CLSI) guidelines. Multivariable logistic regression and receiver operating characteristic (ROC) curve analysis identified independent predictors of fosfomycin resistance.
resultsIn this study, the participants were predominantly male, 242 (55.37%), with a median age of 50 years.
conclusionFosfomycin showed excellent activity against
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.